Histoplasma capsulatum:
¿un agente emergente para Chile?
Author
dc.contributor.author
Rubio Álvarez, Eduardo
Author
dc.contributor.author
Amaro, José
Author
dc.contributor.author
Villavicencio, Leonel
Admission date
dc.date.accessioned
2019-03-18T12:03:45Z
Available date
dc.date.available
2019-03-18T12:03:45Z
Publication date
dc.date.issued
2018
Cita de ítem
dc.identifier.citation
Rev Chilena Infectol 2018; 35 (3): 309-311
Identifier
dc.identifier.issn
07161018
Identifier
dc.identifier.other
10.4067/s0716-10182018000300309
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/167653
Abstract
dc.description.abstract
In the last eleven months, we have diagnosed 9 cases of Histoplasmosis in our country. All patients affected
were from endemic areas of South-America. Here, we wish to inform and prevent to all clinical laboratories from
Chile about the presence of Histoplasma capsulatum in clinical samples. In the same way we want to prepare and
raising awareness of the strengthening of biosecurity measures.